Delivery Order SPE2DB20D3103-SPE2DB24FL5Y4
Award Date
11/20/23
Potential Completion Date
11/21/23
Potential Value
$1.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Ozempic 0.25-0.5 mg/dose pens. The $37,548.83 firm fixed price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of October 25, 2024. The contract is a delivery order and was not designated with a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Ozempic 0.25-0.5 mg/dose pens (3 ml). The contract, valued at $3,006.54, is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency. The contract is a firm fixed-price arrangement with a period of performance ending on March 10, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $74,297.65 firm fixed-price delivery order is for the supply of Ozempic 0.25-0.5 mg/dose pens with a period of performance through September 26, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of medical commodities, including...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ozempic 0.25-0.5 mg/dose pens. The contract, valued at $3,171.12, is a firm fixed-price delivery order with an ultimate completion date of April 25, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical through December 31, 2025. This...
This federal contract award was made by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $12,717.80 firm fixed-price delivery order is for the supply of Ozempic 0.25-0.5 mg/dose pens. The contract has an ultimate completion date of August 20, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which serves...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,959.56, is a delivery order issued by the Defense Logistics Agency (DLA) for the supply of Ozempic 0.25-0.5 mg/dose pens. The contract is a firm-fixed-price arrangement with a completion date of June 28, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $35,044.01, is for the delivery of Ozempic 0.25-0.5 mg/dose pens with a completion date of December 9, 2024. It is a firm-fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) awarded a $1,161.08 firm fixed price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of Ozempic 0.25-0.5 mg/dose pens. This order is placed under Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Ozempic 0.25-0.5 mg/dose pens with a 3 mL volume. The $2,351.58 firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of July 3, 2024. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through December 2025, which serves as the primary vehicle...
This federal contract award is for the delivery of Ozempic 0.25-0.5 mg/dose pens with a 3 mL capacity to the Defense Logistics Agency (DLA). The $1,871.54 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on March 30, 2023. The contract has an ultimate completion date of March 31, 2023 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999...